Latest Headlines

  1. Protolabs Adds Carbon Technology To Its 3D Printing Service

    Digital manufacturer Protolabs (NYSE: PRLB) has added the Carbon platform to its portfolio of production-grade additive manufacturing technologies. With Carbon Digital Light Synthesis™ (DLS), Protolabs’ customers can move into production faster and more cost-efficiently than ever before with 3D printing.

  2. Phillips-Medisize Enters Agreement with Global Pharmaceutical Company to Acquire Exclusive Ownership of Patents for an Innovative Mini-tablet Dispenser

    Phillips-Medisize, a Molex company, announced today an agreement with a Global Pharmaceutical Company, where Phillips-Medisize acquired exclusive ownership of patents supporting an innovative mini-tablet dispenser to accommodate the varied and customized oral dispensing needs of patients. This press release features multimedia. View the full release here: Mini-tablet Dispenser (Photo: Business Wire) “Through its unique working principle, the mini-tablet dispenser will be valuable in pediatrics, geriatrics and oncology where patients often require highly flexible

  3. Qosina President And CEO Scott Herskovitz Joins CEWIT Medical Advisory Board At Stony Brook University

    Qosina is pleased to announce that Scott Herskovitz, President and CEO, has joined the Medical Advisory Board (MAB) of the Center of Excellence in Wireless and Information Technology (CEWIT) at Stony Brook University.

  4. FDA Grants Breakthrough Designation To SoniVie’s TIVUS System To Treat Pulmonary Arterial Hypertension

    SoniVie, an Israeli company developing a novel system for the treatment of PAH, today announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the Therapeutic Intra-Vascular Ultrasound (TIVUS) System in patients with PAH.

  5. Innovenn Launches New Human Factors Business Under The Name Improvita And Opens New State Of The Art Testing Lab

    Innovenn, a leader in Digital Therapeutics, has separated its human factors testing business under a new name Improvita which means; To Improve Life.  Innovenn will now focus purely on digital health care solutions including digital therapeutics and other software to help diagnose, prognose and manage patient care for those with rare diseases. Improvita will focus on human factors testing, ethnographics, user interface testing and user experience testing for medical devices, software as a medical device and combination drug / medical device products. To support the growing business, Improvita also opened a new state of the art testing lab in Madison, Wisconsin.

  6. Orchestra BioMed’s Cardiac Neuromodulation Therapy Device For Hypertension Earns CE Mark

    Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, announced today that it has received CE Mark approval for its Moderato® implantable pulse generator system that delivers BackBeat Cardiac Neuromodulation Therapy™ (CNT) for treatment of hypertension while also providing standard pacemaker functions.

  7. Qosina Carries A New Line Of Securing Clamps For High-Pressure Connections

    Qosina is pleased to stock a variety of Oetiker stainless steel, non-greased StepLess ear clamps that can be used in a wide range of applications across multiple industries. These clamps are ideal for high-pressure connections where leakage is a concern, providing a more secure connection than standard plastic securing clamps.

  8. Oval Medical Technologies Moves To New Location In Cambridge Research Park To Support Pharmaceutical Partners’ Advanced Drug-Delivery Needs

    Oval Medical Technologies Limited (Oval), a leader of patient-centric autoinjectors, has signalled a new stage in its growth with a move to a purpose-designed facility in Cambridge Research Park, U.K.

  9. Stanford Engineers Have Developed Wireless Sensors That Stick To The Skin To Track Our Health

    Stanford engineers have developed experimental stickers that pick up physiological signals emanating from the skin, then wirelessly beam these health readings to a receiver clipped onto clothing. It’s all part of a system called BodyNet.

  10. PRISYM ID To Exhibit At Pharma And Device Packaging And Labeling Europe

    PRISYM ID will proudly be exhibiting at this year’s Pharma and Device Packaging and Labelling Europe event on 10th and 11th September 2019, in Munich, Germany.